LIP expression is regulated by IGF-1R signaling and participates in suppression of anoikis
Open Access
- 19 August 2011
- journal article
- Published by Springer Nature in Molecular Cancer
- Vol. 10 (1) , 100
Abstract
Background: The transcription factor, CCAAT enhancer binding protein-β (C/EBPβ), is expressed as several distinct protein isoforms (LAP1, LAP2 and LIP) that have opposing actions in cellular proliferation and differentiation. Increases in the ratio of LIP/LAP are associated with aggressive, metastatic breast cancer; however, little is known regarding the molecular mechanisms that regulate LIP expression or the biological actions of an increase in the LIP/LAP ratio. Metastasis is highly dependent upon the suppression of anoikis and the role of C/EBPβ and LIP in this anchorage-independent, survival process is currently not known in mammary epithelial cells. IGF-1R signaling is important for the survival of breast cancer cells and crosstalk between IGF-1R and EGFR signaling pathways have been implicated in the development of more aggressive disease. We therefore evaluated in mammary epithelial cells whether IGF-1R signaling regulates the LIP/LAP ratio, analyzed the potential interplay between EGFR and IGF-1R signaling and addressed the biological significance of increased LIP expression in cellular survival and suppression of anoikis.Results: Our data provide the first evidence that IGF-1R signaling regulates LIP expression in an EGFR independent manner to increase the LIP/LAP ratio in mammary epithelial cells. Although crosstalk between IGF-1R signaling and EGFR signaling is detectable in MCF10A cells, this crosstalk is not required for the IGF-1 mediated regulation of LIP expression. Rather, the critical regulator of IGF-1 induced LIP expression appears to be EGFR-independent, Akt activity. Our data also demonstrate that increases in LIP expression promote cell survival via suppression of anoikis. Likewise, knockdown of total C/EBPβ leads to increased cell death and suggest that C/EBPβ expression is important for survival and resistance to anoikis. IGF-1 treatment can partially rescue vector control cells from anoikis; however, cells with reduced C/EBPβ expression do not survive anoikis.Conclusions: Taken together, our data demonstrate that IGF-1R signaling regulates LIP expression in an EGFR independent manner to increase the LIP/LAP ratio in mammary epithelial cells. C/EBPβ expression and elevations in LIP play an important role in regulating cellular survival via suppression of anoikis, in an IGF-1R mediated context or in a manner independent of IGF-1R signaling.Keywords
This publication has 65 references indexed in Scilit:
- Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachmentNature, 2009
- CCAAT/enhancer-binding protein β: its role in breast cancer and associations with receptor tyrosine kinasesExpert Reviews in Molecular Medicine, 2009
- Multiple Mechanisms Are Responsible for Transactivation of the Epidermal Growth Factor Receptor in Mammary Epithelial CellsJournal of Biological Chemistry, 2008
- Lentiviral Transduction of Mammary Stem Cells for Analysis of Gene Function during Development and CancerCell Stem Cell, 2008
- C/EBPβ at the core of the TGFβ cytostatic response and its evasion in metastatic breast cancer cellsCancer Cell, 2006
- Critical Prosurvival Roles for C/EBPβ and Insulin-Like Growth Factor I in Macrophage Tumor CellsMolecular and Cellular Biology, 2004
- Role of the IGF‐I receptor in the regulation of cell–cell adhesion: Implications in cancer development and progressionJournal of Cellular Physiology, 2002
- Activation of BAD by Therapeutic Inhibition of Epidermal Growth Factor Receptor and Transactivation by Insulin-like Growth Factor ReceptorJournal of Biological Chemistry, 2002
- C/EBPβ, but not C/EBPα, is essential for ductal morphogenesis, lobuloalveolar proliferation, and functional differentiation in the mouse mammary glandGenes & Development, 1998
- Activated neu Induces Rapid Tumor ProgressionJournal of Biological Chemistry, 1996